60PResponse rates with talimogene laherparepvec (T-VEC) monotherapy in patients (pts) with stage IIIB–IVM1c melanoma previously treated with checkpoint inhibitor (CPI) therapy: Retrospective analysis of two clinical trials.

Details

Language :

English

ISSN :

09237534

Volume :

29

Database :

Academic Search Index

Journal :

Annals of Oncology

Publication Type :

Academic Journal

Accession number :

133734923

Full Text :

https://doi.org/10.1093/annonc/mdy486.012